CAMP — CAMP4 Therapeutics Balance Sheet
0.000.00%
- $233.12m
- $123.60m
- $3.50m
Annual balance sheet for CAMP4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 83.2 | 38.4 | 64 | 110 |
| Net Total Receivables | 0.84 | 0.922 | 1.09 | 1.5 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 84.4 | 40 | 66.4 | 114 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 16.8 | 13.3 | 10.3 | 2.82 |
| Other Long Term Assets | ||||
| Total Assets | 103 | 54.9 | 78.3 | 118 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 7.95 | 7.81 | 9.6 | 15.5 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 17.9 | 16.5 | 15.2 | 70.1 |
| Redeemable Preferred Stock | ||||
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 84.6 | 38.4 | 63.1 | 47.7 |
| Total Liabilities & Shareholders' Equity | 103 | 54.9 | 78.3 | 118 |
| Total Common Shares Outstanding |